Ich bin auf dem Weg nach München. Und hoffe, dass ich etliche Follower bei den Baader Tradingdays sehen… Der Beitrag 7 günstige Aktien mit starken Gewinnaussichten erschien zuerst auf Tim Schäfer Media.| Tim Schäfer Media
Eli Lilly announced a partnership with chipmaker NVIDIA to build what it claims will be the “most powerful supercomputer owned and operated by a pharmaceutical company.”| STAT
Sometimes the biggest moments at a conference happen backstage. At the annual STAT Summit, that kind of moment involved a pharma CEO and a toddler in a tuxedo.| STAT
It looks likely we'll see oral GLP-1 drugs on the market by next year, with pharmaceutical company Eli Lilly reporting impressive results following a large, robust 72-week trial that saw obese participants lose an average of 27.3 lb, or 12.4% of their body weight with the once-daily pill.| New Atlas
This post was delivered as a Medicine in Crisis lecture at a Pills and Skills for Depression meeting that David Antonuccio organized in Reno Nevada on October 4. Kim Witczak who features throughout the post was a panellist at the meeting. I was in Houston for the Bicentenary – 49 years ago. A few […] The post Health, Care and Science in Real Life first appeared on Dr. David Healy.| Dr. David Healy
Eli Lilly (NYSE:LLY) announced today that it plans to build a new $6.5 billion manufacturing facility at Generation Park in Houston, Texas. The planned next-generation synthetic medicine active pharmaceutical product (API) facility marks the second of four new sites Lilly plans to announce this year. It follows the announcement of a $5 billion manufacturing facility… The post Lilly to build new $6.5B API manufacturing plant in Texas appeared first on Pharmaceutical Processing World.| Pharmaceutical Processing World
Eli Lilly (NYSE:LLY) announced today that it plans to build a $5 billion manufacturing facility in Goochland County, Virginia.| Pharmaceutical Processing World
Serena Williams shares her experience using GLP-1 medications for weight loss, sparking a conversation about health, stigma, and access to care.| DefenderNetwork.com
Eli Lilly and Co. has agreed to buy Verve Therapeutics Inc. for up to $1.3 billion, in a move that bolsters Lilly's push into gene editing for cardiovascular conditions and signals renewed confidence in the sector.| Drug Discovery and Development
A recording of the full FDA Panel on SSRIs and Pregnancy is linked to the last post here. There has been extensive media coverage of this event – and 18 takes on what reporters heard can be found linked to Unsafe Safety Systems on RxISK. Roger McFillin was on thin ice, at the recent FDA […] The post There’s Something About Pregnant Mary first appeared on Dr. David Healy.| Dr. David Healy
Eli Lilly's investment in capital expansion across therapeutic areas in the U.S. now totals more than $50 billion since 2020.| Pharmaceutical Processing World
Purdue University, Eli Lilly and Merck have launched the Young Institute Pharmaceutical Manufacturing Consortium.| Pharmaceutical Processing World
What is Ozempic or Mounjaro? Weight Loss Medication is available for Type 2 Diabetes, Obesity, or high BMI with other co-morbid indications.| The Kellie Kitchen
